Unity Biotechnology, Inc. Deferred Revenue
Unity Biotechnology, Inc. had Deferred Revenue of $0 as of 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2023-03-15
- 2022-12-31: Deferred Revenue, Current $0.00.
- 2022-09-30: Deferred Revenue, Current $0.00.
- 2022-06-30: Deferred Revenue, Current $0.00.
- 2022-03-31: Deferred Revenue, Current $216.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-15 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 |
| 2022-03-31 | $216.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $216.00K 10-K · filed 2023-03-15 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |